Patients with a primary valvular cardiomyopathy etiology (n 85) or severe congenital heart disease (n 27) were also excluded from this analysis. We also excluded 51 patients with a BMI <18.5 kg/m 2 (below the "normal weight" range). Thus, the final cohort con- The presence of CAD was defined as a prior myocardial infarction or any degree of obstruction on coronary imaging. Retrospective chart review was performed for >20% of database subjects to confirm the accuracy of the prospectively entered data.
CARDIOPULMONARY EXERCISE TESTING. Symptomlimited exercise stress testing was conducted by trained exercise physiologists and supervised by a physician. Exercise testing was performed using a treadmill stress in the majority of patients; the alternate option was a stationary bike. The exercise physiologist assigned the patient to the Bruce, modified
Bruce, Cornell 0%, Cornell 5%, Cornell 10%, Naughton, or modified Naughton protocols, appropriate to the patient's physical abilities. Gas exchange data were collected throughout the test using a MedGraphics cardiopulmonary metabolic cart (St. Paul, Minnesota).
Heart rate targets were not used as an endpoint or to judge the adequacy of the test. Blood pressure was manually measured every minute and the heart rate was recorded from an electrocardiogram printed each minute during the test. Electrocardiographic changes and symptoms were also recorded at the end of each stage. Heart rate recovery (HRR) was calculated as peak exercise heart rate minus the heart rate at 1 minute post-exercise. A standard walking cool-down was used during recovery.
The oxygen consumption (VO 2 ) was averaged over Association, digoxin, angiotensin converting enzyme inhibitor/angiotensin receptor blocker, beta blocker, diabetes, smoking, hypertension, hyperlipidemia, atrial fibrillation, rest systolic blood pressure, heart rate recovery, peak oxygen uptake, respiratory exchange rate, peak tidal 
